Tinh dầu và thai kỳ

Four mechanism classes dominate. First, anti-implantation and abortifacient action: Sabinyl acetate prevents embryo implantation in the uterine wall at very low doses in rodents, and Apiole in parsley oils has caused cumulative abortion in humans at 900 mg/day for 8 days.

Second, embryo and fetal neurotoxicity. Thujone, Pulegone and pinocamphone inhibit GABA-A receptors and provoke seizures, and may also disrupt fetal central nervous system development. Camphor has been recovered from the liver, brain and kidney of a stillborn fetus after maternal ingestion of camphorated oil.

Third, estrogen-like activity. (E)-Anethole in oils of Anise, Anise star, Fennel sweet and Fennel bitter shows weak estrogenic activity, sufficient to perturb the hormonal balance of pregnancy.

Fourth, inhibition of angiogenesis. The vascular networks of the placenta and embryo depend on the formation of new vessels. Constituents such as costunolide, dehydrocostus lactone, β-elemene, β-eudesmol, furanodiene and thymoquinone suppress this process, leading to growth restriction or fetal death.

Oral administration gives the highest systemic exposure with near-complete absorption. It is the highest-risk route in pregnancy and is not recommended for any essential oil except under qualified medical supervision.

Dermal exposure is slower but still meaningful, especially over large surface area, with penetration enhancers, or on compromised skin. For permissible oils, a maximum 1 % dilution in a carrier oil is the cautious convention across all three trimesters.

Inhalation gives the lowest systemic load but is not zero. Diffuser use in well-ventilated rooms, short duration, with conventionally safe oils is considered minimal risk. Avoid sustained inhalation of any oil in the prohibited category.

The first trimester (weeks 1-12) spans implantation and organogenesis. It is the most sensitive window for teratogenic agents. The most cautious recommendation is to avoid essential oils entirely during the first trimester, including those classified as safe later in pregnancy.

The second trimester (weeks 13-27) is more stable with respect to structural defects but neural development continues. Permissible oils (see tables below) may be used at maximum 1 % dilution for massage or short-duration inhalation.

The third trimester (week 28 to birth) allows more flexibility. Observational data on aromatherapy in labor suggest reduced need for additional analgesia in some patients. Oils commonly used during labor include Lavender, Chamomile Roman, Jasmine absolute, Frankincense and Neroli.

The table below lists oils to avoid entirely by any route throughout pregnancy and lactation. The basis is high content of constituents with established reproductive toxicity.

Some oils are not prohibited but require concentration limits on skin to avoid cumulative exposure to Citral or other constituents of concern. Citral interferes with retinoic acid synthesis, a signalling molecule for early embryo development.

The following oils have no contraindication data in pregnancy at normal doses (maximum 1 % dilution for massage, short-duration inhalation). The first-trimester avoidance principle still applies.

Lavender, Chamomile Roman, Chamomile German, Neroli, Rose Damask, Sandalwood East Indian, Frankincense, Geranium, Ylang ylang, Bergamot FCF, Lemon distilled, Mandarin, Marjoram sweet, Tea tree, Jasmine absolute.

Note: Peppermint has mixed reports. High menthol exposure can reduce milk secretion with heavy use and should therefore be limited during lactation if milk supply is a concern.

Most essential oil constituents pass into breast milk by passive diffusion. The transferred dose to the infant is typically below 1 % of the maternal dose, but neonates have reduced metabolic and excretory capacity, especially in preterm infants.

The same prohibition list as pregnancy applies. Camphor, Thujone, Pulegone, Methyl salicylate, Sabinyl acetate, Apiole and Safrole are all detectable in milk and all have documented toxicity in neonates.

Avoid applying essential oils directly to the breast area to limit oral exposure in the infant. If body massage is performed at low dilution, wash the breast area before nursing.

Default to avoidance in the first trimester. After week 13, use a maximum 1 % dilution for massage and limit sustained inhalation to under 30 minutes.

Oral use is not recommended in pregnancy except under specific medical direction. Avoid abdominal application without a clear reason.

Do not combine multiple oils from the prohibited list, even at very low concentrations. Cumulative interaction has not been studied in depth.

When in doubt, do not use. Pregnancy is 40 weeks, not permanent.